We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+5.17%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$354B
AUM Growth
-$2.09B
Cap. Flow
-$10.8B
Cap. Flow %
-3.06%
Top 10 Hldgs %
31.88%
Holding
3,380
New
47
Increased
1,010
Reduced
1,565
Closed
56

Sector Composition

Rank Sector Weight
1 Technology 31.85%
2 Financials 12.67%
3 Consumer Discretionary 11.94%
4 Healthcare 9.6%
5 Communication Services 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBIT icon
3251
XBiotech
XBIT
$69.5M
$98.3K ﹤0.01%
24,879
ELEV
3252
DELISTED
Elevation Oncology
ELEV
$98K ﹤0.01%
174,137
PROP icon
3253
Prairie Operating Co
PROP
$77.6M
$97.4K ﹤0.01%
+14,071
New +$117K
CRVO icon
3254
CervoMed
CRVO
$26.4M
$97.3K ﹤0.01%
41,569
+22,104
+114% +$215K
EEX
3255
DELISTED
Emerald Holding
EEX
$96K ﹤0.01%
19,910
AKYA
3256
DELISTED
Akoya BioSciences
AKYA
$93.5K ﹤0.01%
40,827
BIOA
3257
BioAge Labs
BIOA
$541M
$89.4K ﹤0.01%
+15,448
New +$266K
DLHC icon
3258
DLH Holdings
DLHC
$69.7M
$87.9K ﹤0.01%
10,947
NOTE
3259
DELISTED
FiscalNote
NOTE
$86.6K ﹤0.01%
6,747
KYTX icon
3260
Kyverna Therapeutics
KYTX
$481M
$85.5K ﹤0.01%
22,848
INO icon
3261
Inovio Pharmaceuticals
INO
$68.5M
$85.1K ﹤0.01%
46,491
TPIC
3262
DELISTED
TPI Composites
TPIC
$81.4K ﹤0.01%
43,078
ACRV icon
3263
Acrivon Therapeutics
ACRV
$74.9M
$80.7K ﹤0.01%
13,402
-12,377
-48% -$89.9K
INMB icon
3264
INmune Bio
INMB
$54.2M
$77.1K ﹤0.01%
16,518
SCWO icon
3265
374Water
SCWO
$39M
$74.9K ﹤0.01%
10,975
CLYM
3266
Climb Bio
CLYM
$821M
$70.3K ﹤0.01%
39,034
SKIN icon
3267
SkinHealth Systems
SKIN
$87.6M
$69.5K ﹤0.01%
43,730
FBLG icon
3268
FibroBiologics
FBLG
$6.72M
$69.1K ﹤0.01%
1,727
SKYE icon
3269
Skye Bioscience
SKYE
$18.3M
$66.2K ﹤0.01%
23,389
AMPX icon
3270
Amprius Technologies
AMPX
$1.6B
$65.2K ﹤0.01%
23,300
-55,854
-71% -$97.6K
STTK icon
3271
Shattuck Labs
STTK
$692M
$64.2K ﹤0.01%
53,038
BOLD
3272
Boundless Bio
BOLD
$63.8M
$62.4K ﹤0.01%
+21,523
New +$62.7K
VCSA
3273
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$60.3K ﹤0.01%
12,308
OPTU
3274
Optimum Communications Inc
OPTU
$326M
$60.3K ﹤0.01%
+25,000
New +$62.4K
DTI icon
3275
Drilling Tools International
DTI
$79.8M
$55K ﹤0.01%
16,830

Similar funds

Nuveen's Q4 2024 Portfolio in Review

As of Q4 2024, Nuveen held 3,380 positions worth $354B, down 0.59% from $356B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Nuveen withdrew a net $10.8B in Q4 2024, closing 56 positions and reducing 1,565 holdings. Its most notable exit was Primo Water Corporation, an estimated $100M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Nuveen opened a new position in Primo Brands worth $98.3M.

  • Nuveen's largest Q4 2024 buy was Primo Brands: 3,194,733 shares worth $98.3M.
  • Nuveen added most to Tesla in Q4 2024, an estimated $698M increase.
  • Nuveen's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $1.49B.
  • Nuveen fully exited Primo Water Corporation in Q4 2024, selling an estimated $100M.
  • Nuveen's ten largest holdings make up 32% of its $354B portfolio in Q4 2024.
  • Nuveen opened 47 new positions and closed 56 in Q4 2024.
  • Nuveen's portfolio value fell 0.59% quarter-over-quarter to $354B.

Based on Nuveen's 13F filing for Q4 2024, filed 14 Feb 2025.